Alexion Pharmaceuticals Australasia Pty Ltd
Manufacturer / marketing-authorisation holder
Alexion Pharmaceuticals Australasia Pty Ltd — 18 products across 1 markets, 11 brand names. Products are grouped by country; brand names link to their brand page and ingredients to the ingredient or combination page. It is the marketing-authorisation holder recorded by the regulator, not necessarily the factory.
Alexion Pharmaceuticals Australasia Pty Ltd — 18 productos en 1 mercados, 11 nombres comerciales. Los productos se agrupan por país; los nombres comerciales enlazan a su página de marca y los principios activos a la página del principio o de la combinación. Es el titular registrado por el regulador, no necesariamente la fábrica.
Alexion Pharmaceuticals Australasia Pty Ltd —— 共 18 个产品，覆盖 1 个市场、11 个品牌名。产品按国家分组；品牌名链到品牌页，成分链到成分页/组合页。这里记录的是监管数据里的「上市许可持有人」，不一定是生产工厂。
18 products · 1 markets · 11 brand names
18 productos · 1 mercados · 11 marcas
18 个产品 · 1 个市场 · 11 个品牌名
Products by country
AU
Source: compliance.health.gov.au
| Brand | Active ingredient(s) | Form |
|---|---|---|
| KANUMA sebelipase alfa rce 2 mg/mL injection intravenous infusion vial | Sebelipase Alfa | injection |
| KOSELUGO | Selumetinib | capsule |
| KOSELUGO | Selumetinib | capsule |
| KOSELUGO selumetinib 25 mg capsule bottle | Selumetinib Sulfate | capsule |
| KOSELUGO selumetinib 25 mg capsule bottle | Selumetinib Sulfate | capsule |
| SOLIRIS | 依库珠单抗 | injection |
| SOLIRIS eculizumab 300 mg/30 mL concentrated solution for intravenous infusion vial | 依库珠单抗 | injection |
| STRENSIQ asfotase alfa rch 40 mg/1.00 ml solution for injection vial | Asfotase Alfa | injection |
| STRENSIQ asfotase alfa rch 40 mg/1.00 ml solution for injection vial | Asfotase Alfa | injection |
| STRENSIQ asfotase alfa rch 40 mg/1.00 ml solution for injection vial | Asfotase Alfa | injection |
| STRENSIQ asfotase alfa rch 40 mg/1.00 ml solution for injection vial | Asfotase Alfa | injection |
| STRENSIQ asfotase alfa rch 80 mg/0.80 mL injection solution vial | Asfotase Alfa | injection |
| ULTOMIRIS ravulizumab rch 300 mg in 3 mL (100 mg/mL) concentrated solution for injection by intravenous infusion vial | Ravulizumab | injection |
| ULTOMIRIS ravulizumab rch 300 mg in 3 mL (100 mg/mL) concentrated solution for injection by intravenous infusion vial | Ravulizumab | injection |
| Ultomiris | Ravulizumab | injection |
| Ultomiris | Ravulizumab | injection |
| VOYDEYA 50 + 100 mg film-coated tablets, composite bottle pack | Danicopan | tablet |
| VOYDEYA danicopan 100 mg film-coated tablets, bottle | Danicopan | tablet |